Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

The ability to leverage manufacturing analytics for optimized production volumes, increased efficiency, and enhanced cost savings is no longer a ...

For many organizations, SAP S/4HANA serves as a point of transformation to evolve organizational capabilities and meet the new demands ...

For several years, trends in modern medicine have been shifting towards promising treatments in cell and gene therapy. Backing these ...

For consumer products companies, approximately 60% of trade promotion activities don’t break even according to a Nielsen study. As industry ...

For many consumer products manufacturers, the complex deductions management process represents an opportunity for potentially millions in cost savings and ...

With longstanding players in the consumer products industry continuing to acquire new brands (many of them born direct-to-consumer) as a ...

For medical device makers, cutting manufacturing costs has become a strategic imperative in order to appease margin pressures and achieve ...

In today’s consumer landscape, businesses are leveraging data and analytics to meet expectations in all aspects of the consumer experience, ...

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference therapeutics for genetically ...

The shift to personalized medicine, where companies can develop preventive measures and precision treatments to enhance a patient’s unique well-being, ...

Cell therapy, as defined by the American Society of Gene & Cell Therapy, is “the administration of living whole cells ...